Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of UXT mRNA | decreases expression | 12958071
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane affects the expression of UXT mRNA | affects expression | 18648102
|
C053541 |
bicalutamide |
UXT protein affects the susceptibility to bicalutamide | affects response to substance | 19318562
|
C099555 |
CD 437 |
CD 437 results in decreased expression of UXT mRNA | decreases expression | 12958071
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of UXT protein | increases expression | 15585135 16803524
|
D015741 |
Metribolone |
Metribolone promotes the reaction [UXT protein binds to ATR promoter] | affects binding|increases reaction | 19318562
|
D015741 |
Metribolone |
Metribolone promotes the reaction [UXT protein binds to GSTE1 promoter] | affects binding|increases reaction | 19318562
|
D015741 |
Metribolone |
Metribolone promotes the reaction [UXT protein binds to KLK3 promoter] | affects binding|increases reaction | 19318562
|
D015741 |
Metribolone |
Metribolone promotes the reaction [UXT protein binds to NKX3-1 promoter] | affects binding|increases reaction | 19318562
|
D015741 |
Metribolone |
UXT protein affects the reaction [Metribolone results in increased expression of BRIP1 mRNA] | affects reaction|increases expression | 19318562
|
D015741 |
Metribolone |
UXT protein affects the reaction [Metribolone results in increased expression of KLK3 mRNA] | affects reaction|increases expression | 19318562
|
D015741 |
Metribolone |
UXT protein affects the reaction [Metribolone results in increased expression of NKX3-1 mRNA] | affects reaction|increases expression | 19318562
|
D015741 |
Metribolone |
UXT protein affects the susceptibility to Metribolone | affects response to substance | 19318562
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of UXT mRNA | increases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.48 | 17638652 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.90 | 3712494 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.98 | 16511603 17963324 15504547 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.46 | 1440618 11289319 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.44 | 16595493 18608205 16557594 18357371 19217205 16110121 15136595 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
5.11 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.79 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
3.18 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
3.18 | 17971768 18930000 16332177 17088986 16799960 17045692 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.87 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.87 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.55 | 18986760 17066447 16280240 16757204 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
2.94 | 7505956 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.35 | 19486331 9022650 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.11 | 15894690 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.27 | 17016597 16510598 17018589 15001691 17169374 17725105 17172411 18772588 16340194 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 15289873 20501625 18949393 18802399 17255274 16303861 17094418 17695437 17016601 16524972 18288408 18383874 14970324 18509181 17594712 16331619 18448328 15148649 16391804 17401013 16282729 17454858 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.19 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
3.15 | 11298694 12868966 2524372 11906362 14531868 8156756 18759878 8970840 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.79 | 2952479 3621924 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.03 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
4.19 | 9022650 9328219 6482804 18692083 11289319 16192314 9653073 7440962 18289764 8291058 18648102 1440618 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
4.19 | 15131321 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.72 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.72 | 16785472 16337965 17638652 15173087 16481741 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.46 | 6705139 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.96 | 16145905 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.34 | 7505956 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.56 | 18337622 15102660 15162350 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.84 | 6705139 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.30 | 15034207 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.45 | 14714311 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.46 | 9022650 8074119 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.27 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
8.27 | 16985049 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.35 | 15034207 9327722 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
2.56 | 16603448 15113037 18383874 17045692 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
2.69 | 3712494 6587162 1399818 598648 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.01 | 15246190 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.19 | 15086387 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.36 | 14737004 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.84 | 18986760 16757204 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.56 | 3581430 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.72 | 18239605 18600527 16928823 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
3.08 | 6679447 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.61 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.68 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.46 | 3988306 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
3.38 | 17474084 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.74 | 16929163 15113037 19003803 16500647 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.84 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.91 | 6228378 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 19318562 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
2.71 | 19011039 18487222 19240160 15638997 17914592 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.71 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.71 | 18760546 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.26 | 18286688 15538739 16160472 18722050 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.58 | 3692021 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 18396642 17498489 18567086 15786421 17522103 17172411 16951190 19084572 19015929 16424979 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.09 | 6587162 6582329 7505956 1399818 3712494 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.25 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.72 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
5.72 | 16720286 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.14 | 16803524 |